149 related articles for article (PubMed ID: 3052118)
1. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
Stahel E; Mazier D; Guillouzo A; Miltgen F; Landau I; Mellouk S; Beaudoin RL; Langlois P; Gentilini M
Am J Trop Med Hyg; 1988 Sep; 39(3):236-40. PubMed ID: 3052118
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
[TBL] [Abstract][Full Text] [Related]
3. The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents.
Kicic A; Chua AC; Baker E
Anticancer Drug Des; 2001; 16(4-5):195-207. PubMed ID: 12049478
[TBL] [Abstract][Full Text] [Related]
4. Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.
Kicic A; Chua AC; Baker E
Br J Pharmacol; 2002 Mar; 135(6):1393-402. PubMed ID: 11906952
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model.
Ferrer P; Tripathi AK; Clark MA; Hand CC; Rienhoff HY; Sullivan DJ
PLoS One; 2012; 7(5):e37171. PubMed ID: 22629364
[TBL] [Abstract][Full Text] [Related]
6. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
[TBL] [Abstract][Full Text] [Related]
7. Development of tridentate iron chelators: from desferrithiocin to ICL670.
Nick H; Acklin P; Lattmann R; Buehlmayer P; Hauffe S; Schupp J; Alberti D
Curr Med Chem; 2003 Jun; 10(12):1065-76. PubMed ID: 12678677
[TBL] [Abstract][Full Text] [Related]
8. A non-human primate model for the study of oral iron chelators.
Wolfe LC; Nicolosi RJ; Renaud MM; Finger J; Hegsted M; Peter H; Nathan DG
Br J Haematol; 1989 Jul; 72(3):456-61. PubMed ID: 2765410
[TBL] [Abstract][Full Text] [Related]
9. The effect of desferrithiocin, an oral iron chelator, on T-cell function.
Bierer BE; Nathan DG
Blood; 1990 Nov; 76(10):2052-9. PubMed ID: 2242426
[TBL] [Abstract][Full Text] [Related]
10. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine.
Raventos-Suarez C; Pollack S; Nagel RL
Am J Trop Med Hyg; 1982 Sep; 31(5):919-22. PubMed ID: 6751113
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
14. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.
Ferrer P; Vega-Rodriguez J; Tripathi AK; Jacobs-Lorena M; Sullivan DJ
Antimicrob Agents Chemother; 2015 Mar; 59(3):1418-26. PubMed ID: 25512427
[TBL] [Abstract][Full Text] [Related]
16. Desferrithiocin.
Wolfe LC
Semin Hematol; 1990 Apr; 27(2):117-20. PubMed ID: 2349483
[No Abstract] [Full Text] [Related]
17. Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
Baker E; Wong A; Peter H; Jacobs A
Br J Haematol; 1992 Jul; 81(3):424-31. PubMed ID: 1340769
[TBL] [Abstract][Full Text] [Related]
18. Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.
Bergeron RJ; Wiegand J; Bharti N; McManis JS
J Med Chem; 2012 Aug; 55(16):7090-103. PubMed ID: 22889170
[TBL] [Abstract][Full Text] [Related]
19. Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys.
Pollack S; Rossan RN; Davidson DE; Escajadillo A
Proc Soc Exp Biol Med; 1987 Feb; 184(2):162-4. PubMed ID: 3543939
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.
Fritsch G; Sawatzki G; Treumer J; Jung A; Spira DT
Exp Parasitol; 1987 Feb; 63(1):1-9. PubMed ID: 3542546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
